Filing Details
- Accession Number:
- 0001225208-10-003155
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-02-02 12:00:00
- Reporting Period:
- 2010-02-02
- Filing Date:
- 2010-02-02
- Accepted Time:
- 2010-02-02 17:17:29
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 901219 | Human Genome Sciences Inc | HGSI | In Vitro & In Vivo Diagnostic Substances (2835) | 223178468 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1191235 | C David Stump | 14200 Shady Grove Road Rockville MD 20850 | Exec. Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2010-02-02 | 50,000 | $12.56 | 69,576 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2010-02-02 | 50,000 | $27.40 | 19,576 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option - Right to Buy | Disposition | 2010-02-02 | 50,000 | $0.00 | 50,000 | $12.56 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 84,000 | 2010-04-07 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person and Charles Schwab effective 12/9/09.
- These are fully vested and exercisable.
Billionaire Hedge Funds
